QuadMedicine, Inc. (KOSDAQ:464490)
South Korea · Delayed Price · Currency is KRW 3,900.00
-300.00 (-7.14%)
At close: Nov 6, 2026
QuadMedicine Revenue
QuadMedicine had revenue of 1.53B KRW in the quarter ending June 30, 2026, a decrease of -63.38%. This brings the company's total for the last twelve months to 7.14B, down -46.49% year-over-year. In the year 2025, QuadMedicine had annual revenue of 10.70B with 14.99% growth. That makes QuadMedicine the 39,743rd largest company in the world by revenue and 2,479th in South Korea.
Revenue (ttm)
7.14B
Revenue Growth
-46.49%
P/S Ratio
6.75
Revenue / Employee
68.68M
Employees
104
Market Cap
44.78B
Revenue by Geography
- South Korea 10.18B 95.2%
- Europe 514.05M 4.8%
Fiscal year ended Dec 31, 2025 See the full QuadMedicine breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.70B | 1.39B | 14.99% |
| Dec 31, 2024 | 9.30B | 8.29B | 819.58% |
| Dec 31, 2023 | 1.01B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.